HopeStage
Back to all studies
CompletedNCT02188121

Cardiovascular Risk Treatment for People With Serious Mental Illness

About this titleRead the official source — NCT02188121
Medication studyAges 18–89United StatesSchizophrenia
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 89 years.

Listed locations
BelmontSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateFebruary 2015
Recruitment status
Completed
Enrollment listed in the registry
227
Sponsor
Mclean Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 89 Years
Official registry ID
NCT02188121
Official title
Show the full official title

Fixed Dose Intervention Trial of New England Enhancing Survival in Serious Mental Illness Patients

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Belmont

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Mclean Hospital, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including Simvastatin and Losartan.

Who was this study for?

Listed age limits: 18 years to 89 years.

Want to explore more studies?

Explore studies